|
Business PlanObjectives:
 |
Develop ANDAs (Generic version of Off-Patented Branded Drugs) to US market. |
|
Develop Generic Drug Products to other Global Markets. |
|
Contract Manufacture Pharmaceutical Drug Products to other Companies. |
Achievements:
|
USFDA Approved Generic Bactrim (Sulfamethoxazole + Trimethoprim - SMZ) for US Market in October 2005.
|
|
SMZ Product(Generic Bactrim) is First Manufactured in US in 2006. |
|
SMZ Product (Generic Bactrim) is First launched in US in May 2006. |
|
USFDA approved the Site Transfer of SMZ Product Manufacturing to India in June 2010. |
|
SMZ Product from India is launched in US in November 2010. |
|
|
